Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
Department of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.
Cells. 2021 Mar 5;10(3):564. doi: 10.3390/cells10030564.
The disruption of the immune tolerance induces autoimmunity such as systemic lupus erythematosus and vasculitis. A chromatin-binding non-histone protein, high mobility group box 1 (HMGB1), is released from the nucleus to the extracellular milieu in particular environments such as autoimmunity, sepsis and hypoxia. Extracellular HMGB1 engages pattern recognition receptors, including Toll-like receptors (TLRs) and the receptor for advanced glycation endproducts (RAGE). While the HMGB1-RAGE axis drives inflammation in various diseases, recent studies also focus on the anti-inflammatory effects of HMGB1 and RAGE. This review discusses current perspectives on HMGB1 and RAGE's roles in controlling inflammation and immune tolerance. We also suggest how RAGE heterodimers responding microenvironments functions in immune responses.
免疫耐受的破坏会诱导自身免疫,如系统性红斑狼疮和血管炎。一种染色质结合的非组蛋白蛋白,高迁移率族蛋白 B1(HMGB1),在特定环境(如自身免疫、败血症和缺氧)中从细胞核释放到细胞外环境。细胞外 HMGB1 与模式识别受体(包括 Toll 样受体 (TLR) 和晚期糖基化终产物受体 (RAGE))结合。虽然 HMGB1-RAGE 轴在各种疾病中驱动炎症,但最近的研究也集中在 HMGB1 和 RAGE 的抗炎作用上。这篇综述讨论了当前关于 HMGB1 和 RAGE 在控制炎症和免疫耐受中的作用的观点。我们还提出了 RAGE 异二聚体如何响应微环境在免疫反应中的功能。